Top 10 Insight Stories from 2013

As 2013 comes to a close, we’re looking back at some of our favorite Insight posts from the last year. From inspiring patient stories to important research, here is our top 10 list:

New Study: Nuts Linked to Reduced Risk of Pancreatic and Other Cancers

An analysis of data from the decades-long Nurses’ Health Study revealed that women who ate a one-ounce serving of nuts – any kind of nuts – two or more times a week had a 35 percent lower risk of pancreatic cancer than women who abstained from them. That’s a significant and encouraging piece of news for a field that has had far too little.

New Research Shows Progress in Breast Cancer Treatment

The 36th annual San Antonio Breast Cancer Symposium, which ran from Dec. 10-14, brought news of significant advances against a disease that strikes more than 230,000 women and 2,000 men in the United States each year. The more than 1,000 research papers presented by thousands of scientists and physicians ranged from laboratory explorations of the basic biology of the disease to studies that may change the treatment for patients with a variety of breast cancer subtypes. Here are summaries of the findings of several high-profile studies:

Is there a Link Between Dairy and Cancer?

While some people claim dairy products can prevent cancer, others argue that dairy could actually increase the cancer risk. There are also concerns that dairy can potentially spur growth in hormone-sensitive cancers, including some forms of ovarian and breast cancer. Is there a relationship between dairy and cancer? We consulted with the Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) Nutrition Department to find out.

Hodgkin Lymphoma: Five Things You Need to Know

Approximately 173,000 people in the United States are living with Hodgkin lymphoma, or are in remission. Less common than non-Hodgkin lymphoma, Hodgkin lymphoma (sometimes referred to as Hodgkin’s lymphoma) is a malignancy of B lymphocytes, an important cell in the immune system. This malignant B cell is known as the Reed-Sternberg cell. Arnold Freedman, MD, clinical director of the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program, answers some questions about the disease:

Chat Live with a Dana-Farber Lymphoma Expert

Lymphoma: How do we treat it? Where are future therapies headed? On Wednesday, Dec. 18, Ann LaCasce, MD, of the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program will answer your questions about lymphoma care in a live video webchat. The 45-minute chat starts at 1 p.m. EST and will air live on Dana-Farber’s YouTube page. LaCasce will discuss current treatment options as well as future therapies for lymphoma. If you have a question for Dr. LaCasce, email webchats@dfci.harvard.edu. You can also submit questions by sending us a Tweet @DanaFarber using the hashtag #DFCIWebchat. Bookmark the webchat video page and …

Continue reading

Fighting the Lung Cancer Stigma

Despite the research, the promising new drugs, the many ongoing clinical trials, lung cancer remains a disease that affects too many people, too often. For patients and family members, the disease carries an added burden: a stigma that lung cancer and smoking go hand in hand, and that lung cancer patients brought this on themselves. Not only must these patients and family members face their disease, but they also must carry the guilt and blame that some people cast their way. When we posted a recent infographic on smoking and cancer, we unintentionally helped promote that stigma. We’re deeply sorry …

Continue reading